Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer

The aim of this study was to address one of the major challenges of the actual era of nanomedicine namely, the bioavailability of poorly water soluble drugs such as Silymarin. We developed new, biodegradable, and biocompatible nanosized shuttles for Silymarin targeted delivery in colon-cancer cells....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Radu, Ionut-Cristian, Hudita, Ariana, Zaharia, Catalin, Stanescu, Paul O., Vasile, Eugenia, Iovu, Horia, Stan, Miriana, Ginghina, Octav, Galateanu, Bianca, Costache, Marieta, Langguth, Peter, Tsatsakis, Aristidis, Velonia, Kelly, Negrei, Carolina
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2017
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5539237/
https://ncbi.nlm.nih.gov/pubmed/28824432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00508
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars